Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
Just nowQuarterly Activities Report - March 2026
Just nowAppendix 4C and Quarterly Activities Report - March 2026
Just nowING completes share buyback and announces new programme of up to €1.0 billion
Just nowargenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
Just nowSanthera Proposes Dr. Srishti Gupta as New Member of the Board of Directors
Caribou Biosciences Inc logo

Caribou Biosciences Inc

About

Caribou Biosciences Inc (NASDAQ:CRBU) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 31 2026
Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy
Mar 5 2026
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Feb 17 2026
Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample
Feb 12 2026
Caribou Biosciences to Participate in Upcoming Investor Conferences
Feb 4 2026
Caribou Biosciences Announces Late-Breaking Presentations at the 2026 Tandem Meetings of ASTCT® and CIBMTR®

Financials

Revenue
$11.16 M
Market Cap
$187.48 M
EPS
-1.59

Community Chat

Ask AI

6ix6ix